CERS stock

Cerus Corporation (CERS) stock news · rev $233.8M

Cerus Corporation (CERS) is a medical devices company listed on US.

This CERS news page leads with what Cerus Corporation filed — not a scraped headline mill.

No cached 8-K sentence for CERS yet. We will not pad this page with generic market recap.

Latest reported CERS revenue for 2025-12-31 was $233.8M. Net income was -$15.6M. Revenue was up 16.1% from 2024-12-31 to 2025-12-31. CERS currently screens at market cap $294.4M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the CERS stock page; for the tape open the quote page.

CERS stock news FAQ

What are CERS's latest revenue and net income?

Latest cached Cerus Corporation (CERS) revenue for Dec 31, 2025 was $233.8M. Net income was -$15.6M. Statements: https://lician.com/financials/cers

How did CERS revenue change from the prior cached period?

Cached Cerus Corporation (CERS) revenue was up 16.1% from $201.3M (Dec 31, 2024) to $233.8M (Dec 31, 2025). Statements: https://lician.com/financials/cers

What is CERS's market cap?

Cerus Corporation (CERS) market cap is $294.4M on the latest cached fundamentals snapshot.

What kind of company is CERS?

Cerus Corporation (CERS) is a medical devices company listed on US.

Where is CERS stock news listed?

Cached stock news for Cerus Corporation (CERS) is listed at https://lician.com/news/cers. Filings: https://lician.com/sec/cers

Not investment advice.

Full CERS analysis